{
    "clinical_study": {
        "@rank": "38433", 
        "arm_group": [
            {
                "arm_group_label": "Genesis French-Belgium Study", 
                "description": "Cross-sectional, multi-center, binational (Belgian and France) study designed to evaluate the genetic components of diabetic nephropathy. It is a cohort with 501 patients, including 279 individuals (55.7%) with diagnosis of diabetic nephropathy."
            }, 
            {
                "arm_group_label": "GENEDIAB", 
                "description": "Cross-sectional, multi-center, binational (Belgian and France) study designed to evaluate the genetic components of diabetic nephropathy. It is a cohort with 444 patients, including 310 individuals (69.8%) with diagnosis of diabetic nephropathy."
            }, 
            {
                "arm_group_label": "Brazilian cohort", 
                "description": "The cohort comprised 451 patients with type 1 diabetes for more than 10 years (56% women; aged 36 \u00b1 11 years, mean \u00b1 SD) recruited in diabetes/endocrinology departments of three university hospitals in the cities of S\u00e3o Paulo (SP), Campinas (SP) and Porto Alegre (RS), Brazil."
            }
        ], 
        "biospec_descr": {
            "textblock": "Whole Blood"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "Oxidative stress is involved in the pathophysiology of diabetic nephropathy. The\n      superoxide-generating nicotinamide adenine dinucleotide phosphate-oxidase 2 (NOX2, encoded\n      by the CYBB gene) and the antioxidant enzyme glutathione peroxidase 4 (GPX4) play opposing\n      roles in the balance of cellular redox status. In the present study, we investigated\n      associations of single nucleotide polymorphisms (SNPs) in the regulatory regions of CYBB and\n      GPX4 with kidney disease in patients with type 1 diabetes."
        }, 
        "brief_title": "Sex-specific Association With Kidney Disease", 
        "completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "condition": "Diabetic Nephropathy", 
        "condition_browse": {
            "mesh_term": [
                "Diabetic Nephropathies", 
                "Kidney Diseases"
            ]
        }, 
        "detailed_description": {
            "textblock": "In the present study, three cohorts of type 1 diabetic patients (one Brazilian and two\n      French/Belgium cohorts) were studied for the association with diabetic nephropathy (DN) with\n      a total of 1396 patients. The patients were classified according to the urinary\n      albumin-to-creatinine ratio (ACR) or urinary albumin excretion rate (UAER) in absence of\n      nephropathy, defined as ACR <30 mg/g or UAER < 20 \u00b5g/min or < 20 mg/L and plasma creatinine\n      <1.7 mg/dL; incipient nephropathy, defined as persistent microalbuminuria (ACR 30 - 300 mg/g\n      of creatinine or UAER 20 - 200 \u00b5g/min or 20 - 200 mg/L) and plasma creatinine <1.7 mg/dL;\n      established diabetic nephropathy, defined as past or present macroalbuminuria (ACR >300 mg/g\n      of creatinine or UAER >200 \u00b5g/min or > 200 mg/L) and plasma creatinine <1.7 mg/dL; advanced\n      diabetic nephropathy, defined as past or present macroalbuminuria, plasma creatinine >1.7\n      mg/dL and any renal replacement therapy. Genotyping of polymorphisms was performed by Real\n      Time PCR using fluorescent-labelled probes."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Overt 10 years of Diabetes Mellitus (Brazilian cohort)\n\n          -  Diagnostic of diabetes before the age of 35 years, with initial ketosis and\n             requirement for permanent insulin treatment within 1 year of diagnosis and past or\n             present diagnosis of diabetic retinopathy. (Genesis cohort).\n\n          -  Diagnostic of diabetes before the age of 35 years and past or present diagnosis of\n             severe diabetic retinopathy. (GENEDIAB cohort).\n\n        Exclusion Criteria:\n\n          -  Patients presenting autoimmune diseases, HIV or HCV infections (Brazilian cohort)\n\n          -  Patients with glomerular filtration rate < 60 mL min\u22121 1.73 m2 without diabetic\n             retinopathy (Brazilian cohort)\n\n          -  Terminal cancer and personal disability (GENEDIAB cohort)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "11 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Three cohorts pf type 1 diabetic patients were used for the present study. The first one\n        is a Brazilian cohort with 451 patients recruited in diabetes/endocrinology departments of\n        three university hospitals in the cities of S\u00e3o Paulo (SP), Campinas (SP) and Porto Alegre\n        (RS), Brazil between October 2004 and October 2012. The second one is a French/Belgium\n        cohort with 501 patients recruited from both countries between November 1998 to December\n        2000. The third cohort is a French/Belgium cohort with 444 patients recruited from both\n        countries between May 1994 to April 1995."
            }
        }, 
        "enrollment": {
            "#text": "1396", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 11, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01810822", 
            "org_study_id": "FMUSP-LIM25-0002"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "oxidative stress", 
            "genetic susceptibility", 
            "GPX4", 
            "NOX2"
        ], 
        "lastchanged_date": "March 13, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "S\u00e3o Paulo", 
                    "country": "Brazil", 
                    "state": "SP", 
                    "zip": "01246-000"
                }, 
                "name": "Faculty of Medicine from University of S\u00e3o Paulo"
            }
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_groups": "3", 
        "official_title": "Sex-specific Associations of Variants in the Regulatory Regions of NADPH Oxidase-2 (CYBB) and Gluthatione Peroxidase 4 (GPX4) Genes With Kidney Disease in Type 1 Diabetes.", 
        "overall_official": [
            {
                "affiliation": "Clinical Hospital/Faculty of Medicine from University of S\u00e3o Paulo", 
                "last_name": "Maria L C\u00f4rrea-Giannela, Doctor", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "INSERM U695", 
                "last_name": "Gilberto Velho, Doctor", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Brazil: National Committee of Ethics in Research", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 1994", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Albumin to Creatinine Ratio", 
            "safety_issue": "Yes", 
            "time_frame": "Two Years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01810822"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of Sao Paulo General Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Sao Paulo General Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 1994", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "March 2013"
    }
}